SpaceX completed its acquisition of xAI in February 2026, valuing the AI company at $250 billion in an all-share deal that put the combined entity at $1.25 trillion, per CNBC. That transaction was the largest corporate merger on record, and it completed the consolidation of Elon Musk's AI assets under one roof. Here is a map of his four active fronts, as of June 2026.
Inside Elon Musk's AI Portfolio: SpaceX-xAI, Robotaxi, Neuralink
SpaceX absorbed xAI at $250B in February 2026; Tesla's unsupervised Robotaxi is live in Dallas and Houston; Neuralink has 21 PRIME study patients. A portfolio map of Musk's four AI fronts as of June 2026.

Related startups
xAI Absorbed Into SpaceX at a Record Valuation
One month before the merger closed, xAI completed a $20 billion Series E round at a $230 billion pre-money valuation from investors including Nvidia, Cisco, and Fidelity, according to CNBC. That put the company's implied value roughly ten times higher than the $24 billion it carried after its May 2024 Series B, which raised $6 billion, according to Bloomberg's coverage of that round. The pace of re-rating is unusual even for AI companies: xAI was founded in March 2023.
The SpaceX acquisition, announced February 2, 2026, was structured as an all-share exchange at a ratio of 0.1433 SpaceX shares per xAI share, per TechCrunch. Musk's stated rationale, in a public blog post, was that terrestrial data centers cannot meet global AI electricity demand at scale, but orbital data centers fed by Starlink's satellite constellation could. Grok, the Colossus supercomputer in Memphis, and the xAI API now operate as divisions of SpaceX. The combined xAI-plus-X segment generated $3.2 billion in revenue during 2025, up 22 percent year-on-year, against a $6.36 billion operating loss, per financial research platform Sacra. The Financial Times has reported that SpaceX is targeting a valuation as high as $1.5 trillion and a raise of up to $50 billion in its IPO, meaning xAI's revenue trajectory will be a central disclosure in that prospectus.
Earlier deals in the xAI infrastructure build-out are documented in StartupHub's coverage of xAI's $5.3 billion debt-and-equity round from 2025, which funded the initial Colossus cluster expansion.
Tesla Deploys Unsupervised Robotaxi in Dallas and Houston
Tesla launched unsupervised Robotaxi rides in Dallas and Houston in April 2026, expanding beyond the supervised beta it opened in Austin in June 2025, according to Tesla's first-quarter 2026 10-Q filing with the SEC. The Cybercab, a purpose-built autonomous vehicle without a steering wheel or pedals, is assembled at Tesla's Gigafactory in Texas. On the Q1 2026 earnings call, Musk said robotaxi revenue would "not be material" in 2026, with meaningful contribution expected in 2027. The statement was consistent with analyst consensus compiled by Visible Alpha, which projects Cybercab revenues at roughly $1 billion for 2026, less than two percent of Tesla's total automotive sales, per a recap published by HeyGoTrade.
The capital commitment backing those deployments is substantial. Tesla guided for $25 billion in capital expenditure for 2026, weighted toward AI infrastructure and Full Self-Driving neural-network training compute, per the same SEC filing. That ratio, $25 billion invested against $1 billion projected, reflects the front-loaded nature of Musk's autonomous-driving thesis: the compute and fleet build-out must precede meaningful revenue by at least one year. Tesla's FSD stack and the Cybercab operate entirely separately from the SpaceX AI division; Tesla remains an independent public company.
Neuralink Reaches 21 Patients; Grok Shifts to Paid
Neuralink enrolled its 21st PRIME study participant by February 2026, up from five participants in February 2025 and twelve by September 2025, according to Neuralink's own "Two Years of Telepathy" update and data logged on ClinicalTrials.gov. The PRIME study uses the N1 chip to enable high-resolution cursor control via neural signal; the company has publicly acknowledged that electrode thread retraction from cortical tissue progressively degrades signal quality over months. Musk announced in early 2026 that Neuralink would begin high-volume production of its implant and transition to a nearly fully automated surgical procedure, per reporting in FierceBiotech. The participant registry has begun accepting applications from Canada, with UK expansion under evaluation.
On the fourth front, X, Bloomberg reported in January 2026 that Grok restricted its image-generation feature to paid X Premium subscribers, converting a previously unlimited free capability into a paywall. The Grok product line formally became part of SpaceX's AI division following the February merger; X itself remains a separate operating entity but distributes Grok as its primary AI product. Musk has not disclosed subscriber counts for X Premium.
What It Means
The SpaceX-xAI merger completed a vertical consolidation that spans compute infrastructure (Colossus, planned orbital data centers via Starlink), AI models (Grok), autonomous mobility (Tesla FSD and Cybercab), and neural interfaces (Neuralink). SpaceX serves as the anchor entity, and its planned IPO will put a public-market price on each component for the first time. The four fronts are at different maturity levels: xAI's segment is generating $3.2 billion in combined revenue, Tesla's robotaxi program is live in three cities with $1 billion in 2026 projections, and Neuralink has 21 patients. What ties them together is a single shared constraint: Musk must allocate capital and management attention across all four simultaneously, while guiding the largest IPO in corporate history.
Sources
CNBC: Elon Musk's xAI raises $20 billion from investors including Nvidia, Cisco, Fidelity
CNBC: Musk's xAI, SpaceX combo is the biggest merger of all time, valued at $1.25 trillion
TechCrunch: Elon Musk's SpaceX officially acquires xAI, with plan to build data centers in space
SEC: Tesla Q1 2026 10-Q (TSLA-20260331)
Bloomberg: Musk's Grok Limits Image Generation to Paid Users on X
Neuralink: Two Years of Telepathy (February 2026 update)
FierceBiotech: Neuralink to kick-start high-volume production of brain-computer interface devices
ClinicalTrials.gov: PRIME Study (NCT06429735)
Sacra: xAI revenue and financial data
HeyGoTrade: Tesla Q1 2026 Earnings Recap: Robotaxi & $25B Capex Pivot
Editorial standards: every claim is sourced. Tips: [email protected]